Knott David M decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 10.1% during the 1st quarter, HoldingsChannel reports. The fund owned 8,901 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the period. Knott David M’s holdings in Gilead Sciences were worth $671,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Wealthcare Advisory Partners LLC bought a new position in Gilead Sciences in the 3rd quarter valued at approximately $133,000. Advisors....More>>>